Prosecution Insights
Last updated: May 29, 2026
Application No. 18/576,145

SYSTEM AND METHOD FOR SURGICAL INSTRUMENT USE PREDICTION

Non-Final OA §102§112
Filed
Jan 03, 2024
Priority
Aug 03, 2021 — provisional 63/228,656 +1 more
Examiner
BERTRAM, ERIC D
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Covidien LP
OA Round
2 (Non-Final)
81%
Grant Probability
Favorable
2-3
OA Rounds
9m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
1032 granted / 1274 resolved
+11.0% vs TC avg
Moderate +13% lift
Without
With
+12.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
29 currently pending
Career history
1313
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
62.2%
+22.2% vs TC avg
§102
23.6%
-16.4% vs TC avg
§112
4.1%
-35.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1274 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 2/19/2026 was filed in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Response to Arguments Applicant’s amendments and associated arguments filed 2/3/2026, with respect to the previous rejections of the claims have been fully considered and are persuasive. Therefore, the rejections have been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Sillman et al. Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 3-7 and 15-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Specifically, claims 3 and 15 recite “accessing…a maximum use time”. However, claims 1 and 13 already recite “accessing a maximum use time.” The repetitive claiming of this limitation is confusing and renders the claims indefinite. Furthermore, claims 4 and 16 recite “accessing…a number of previous uses [and] a previous use time”. However, claims 1 and 13 already recite “accessing…a number of previous uses [and] a previous use time”. The repetitive claiming of this limitation is confusing and renders the claims indefinite. Claims 5-7 depend from claims 3 and 4 and are indefinite based on their association. Claim Rejections - 35 USC § 112(d) The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 2 and 14 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Specifically, claims 2 and 14 recite that “accessing the usage data” in claims 1 and 13, respectively, includes “accessing maximum life data and previous use data.” However, claims 1 and 13 already recite that “accessing the usage data” includes “a maximum use time, a number of previous uses, and a previous use time.” Therefore, claims 1 and 13 already recite “accessing maximum life data and previous use data” and as such claims 2-7 and 14-16 fail to further limit claims 1 and 13. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-7, 10-16, 19 and 20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Sillman et al. (US 200/0156285, hereinafter Sillman). Regarding claims 1-7, 10-16, 19 and 20, Sillman discloses a surgical robotic system as seen in figures 1-10, including a plurality of robotic arms and a surgical instrument 54 coupled to each arm (par. 0035). A controller is configured to access continuously updated usage data from a storage device pertaining to the surgical instrument, including maximum use time, a number of maximum uses, a number of previous uses and a previous use time (par. 0068 and 0085). The system can calculate an average use time based on the previous use time and the number of previous uses and can calculate a predicted number remaining for the surgical instrument based on the maximum use time and the average use time (par. 0085). The surgical instrument can be disabled in response to user input based on the predicted number of uses remaining such that the threshold number being exceeded equates to an expired flag being set to true, in that the surgical instrument is considered expired by the system (par. 0085, 0073). An error message acting as a “usage indicator status” is displayed (par. 0073). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric D Bertram whose telephone number is (571)272-3446. The examiner can normally be reached Monday-Friday 8am-6pm Central Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eric D. Bertram/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Jan 03, 2024
Application Filed
Nov 03, 2025
Non-Final Rejection mailed — §102, §112
Feb 03, 2026
Response Filed
Mar 02, 2026
Final Rejection mailed — §102, §112
May 01, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636774
ARM ASSEMBLY FOR SURGICAL ROBOT
3y 0m to grant Granted May 26, 2026
Patent 12636191
DEVICES AND METHODS FOR IMPROVED FOLLOWABILITY IN LASER-BASED OCULAR PROCEDURES
2y 9m to grant Granted May 26, 2026
Patent 12629531
IMPLANTABLE DEFIBRILLATION SYSTEM
4y 3m to grant Granted May 19, 2026
Patent 12629530
DEFIBRILLATION ASSEMBLY ENERGIZABLE THROUGH MAGNET REMOVAL
1y 7m to grant Granted May 19, 2026
Patent 12614633
ELECTROCARDIOGRAM WAVE SEGMENTATION USING MACHINE LEARNING
3y 6m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
81%
Grant Probability
94%
With Interview (+12.6%)
3y 2m (~9m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1274 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month